These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

281 related items for PubMed ID: 31107869

  • 1. Pharmacokinetics, safety, and efficacy of a single co-administered dose of diethylcarbamazine, albendazole and ivermectin in adults with and without Wuchereria bancrofti infection in Côte d'Ivoire.
    Edi C, Bjerum CM, Ouattara AF, Chhonker YS, Penali LK, Méité A, Koudou BG, Weil GJ, King CL, Murry DJ.
    PLoS Negl Trop Dis; 2019 May; 13(5):e0007325. PubMed ID: 31107869
    [Abstract] [Full Text] [Related]

  • 2. Safety and efficacy of mass drug administration with a single-dose triple-drug regimen of albendazole + diethylcarbamazine + ivermectin for lymphatic filariasis in Papua New Guinea: An open-label, cluster-randomised trial.
    Tavul L, Laman M, Howard C, Kotty B, Samuel A, Bjerum C, O'Brian K, Kumai S, Amuga M, Lorry L, Kerry Z, Kualawi M, Karl S, Makita L, John LN, Bieb S, Wangi J, Weil GJ, Goss CW, Tisch DJ, Pomat W, King CL, Robinson LJ.
    PLoS Negl Trop Dis; 2022 Feb; 16(2):e0010096. PubMed ID: 35139070
    [Abstract] [Full Text] [Related]

  • 3. Efficacy, Safety, and Pharmacokinetics of Coadministered Diethylcarbamazine, Albendazole, and Ivermectin for Treatment of Bancroftian Filariasis.
    Thomsen EK, Sanuku N, Baea M, Satofan S, Maki E, Lombore B, Schmidt MS, Siba PM, Weil GJ, Kazura JW, Fleckenstein LL, King CL.
    Clin Infect Dis; 2016 Feb 01; 62(3):334-341. PubMed ID: 26486704
    [Abstract] [Full Text] [Related]

  • 4. An open label, block randomized, community study of the safety and efficacy of co-administered ivermectin, diethylcarbamazine plus albendazole vs. diethylcarbamazine plus albendazole for lymphatic filariasis in India.
    Jambulingam P, Kuttiatt VS, Krishnamoorthy K, Subramanian S, Srividya A, Raju HKK, Rahi M, Somani RK, Suryaprakash MK, Dwivedi GP, Weil GJ.
    PLoS Negl Trop Dis; 2021 Feb 01; 15(2):e0009069. PubMed ID: 33591979
    [Abstract] [Full Text] [Related]

  • 5. Efficacy and Safety of a Single Dose of Ivermectin, Diethylcarbamazine, and Albendazole for Treatment of Lymphatic Filariasis in Côte d'Ivoire: An Open-label Randomized Controlled Trial.
    Bjerum CM, Ouattara AF, Aboulaye M, Kouadio O, Marius VK, Andersen BJ, Weil GJ, Koudou BG, King CL.
    Clin Infect Dis; 2020 Oct 23; 71(7):e68-e75. PubMed ID: 31641754
    [Abstract] [Full Text] [Related]

  • 6. Semiannual Treatment of Albendazole Alone is Efficacious for Treatment of Lymphatic Filariasis: A Randomized Open-label Trial in Cote d'Ivoire.
    Ouattara AF, Bjerum CM, Aboulaye M, Kouadio O, Marius VK, Andersen B, Lew D, Goss CW, Weil GJ, Koudou BG, King CL.
    Clin Infect Dis; 2022 Jul 06; 74(12):2200-2208. PubMed ID: 33674871
    [Abstract] [Full Text] [Related]

  • 7. Safety and efficacy of co-administered diethylcarbamazine, albendazole and ivermectin during mass drug administration for lymphatic filariasis in Haiti: Results from a two-armed, open-label, cluster-randomized, community study.
    Dubray CL, Sircar AD, Beau de Rochars VM, Bogus J, Direny AN, Ernest JR, Fayette CR, Goss CW, Hast M, O'Brian K, Pavilus GE, Sabin DF, Wiegand RE, Weil GJ, Lemoine JF.
    PLoS Negl Trop Dis; 2020 Jun 06; 14(6):e0008298. PubMed ID: 32511226
    [Abstract] [Full Text] [Related]

  • 8. Safety and tolerability of moxidectin and ivermectin combination treatments for lymphatic filariasis in Côte d'Ivoire: A randomized controlled superiority study.
    Bjerum CM, Koudou BG, Ouattara AF, Lew D, Goss CW, Gabo PT, King CL, Fischer PU, Weil GJ, Budge PJ.
    PLoS Negl Trop Dis; 2023 Sep 06; 17(9):e0011633. PubMed ID: 37721964
    [Abstract] [Full Text] [Related]

  • 9. Identifying co-endemic areas for major filarial infections in sub-Saharan Africa: seeking synergies and preventing severe adverse events during mass drug administration campaigns.
    Cano J, Basáñez MG, O'Hanlon SJ, Tekle AH, Wanji S, Zouré HG, Rebollo MP, Pullan RL.
    Parasit Vectors; 2018 Jan 31; 11(1):70. PubMed ID: 29382363
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. A Trial of a Triple-Drug Treatment for Lymphatic Filariasis.
    King CL, Suamani J, Sanuku N, Cheng YC, Satofan S, Mancuso B, Goss CW, Robinson LJ, Siba PM, Weil GJ, Kazura JW.
    N Engl J Med; 2018 Nov 08; 379(19):1801-1810. PubMed ID: 30403937
    [Abstract] [Full Text] [Related]

  • 12. Treatment of Brugia timori and Wuchereria bancrofti infections in Indonesia using DEC or a combination of DEC and albendazole: adverse reactions and short-term effects on microfilariae.
    Supali T, Ismid IS, Rückert P, Fischer P.
    Trop Med Int Health; 2002 Oct 08; 7(10):894-901. PubMed ID: 12358626
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. An open label, randomized clinical trial to compare the tolerability and efficacy of ivermectin plus diethylcarbamazine and albendazole vs. diethylcarbamazine plus albendazole for treatment of brugian filariasis in Indonesia.
    Supali T, Djuardi Y, Christian M, Iskandar E, Alfian R, Maylasari R, Destani Y, Lomiga A, Minggu D, Lew D, Bogus J, Weil GJ, Fischer PU.
    PLoS Negl Trop Dis; 2021 Mar 08; 15(3):e0009294. PubMed ID: 33780481
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Low transmission of Wuchereria bancrofti in cross-border districts of Côte d'Ivoire: A great step towards lymphatic filariasis elimination in West Africa.
    Yokoly FN, Zahouli JBZ, Méite A, Opoku M, Kouassi BL, de Souza DK, Bockarie M, Koudou BG.
    PLoS One; 2020 Mar 08; 15(4):e0231541. PubMed ID: 32282840
    [Abstract] [Full Text] [Related]

  • 20. Tolerability and efficacy of single dose diethylcarbamazine (DEC) alone or co-administration with Ivermectin in the clearance of Wuchereria bancrofti microfilaraemia in Pondicherry, South India.
    Pani SP, Reddy GS, Vanamail P, Venkatesvarlou N, Das LK, Vijayan AP.
    J Commun Dis; 2004 Dec 08; 36(4):240-50. PubMed ID: 16506546
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 15.